In a crossover trial of 16 healthy participants, naproxen inhibited COX-2 more than celecoxib (62.9% vs 35.7%) and raised systolic blood pressure by 4.0 mm Hg relative to celecoxib; systolic change vs placebo tracked COX-2 inhibition.
RCTn = 16
Theken et al. Degree of Cyclooxygenase-2 Inhibition Modulates Blood Pressure Response